Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Improving timeliness and equity in germline genetic testing for pancreatic ductal adenocarcinoma patients: A comparative analysis and future strategies.
Authors
Xianghui Zou
Department of Internal Medicine, North Shore University Hospital & Long Island Jewish Medical Center, New Hyde Park, NY
Xianghui Zou , Baho Sidiqi , Cathy Nguyen , Ellen Chen , Noah D. Kauff , Daniel King
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Cancer Disparities
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 611)
DOI
10.1200/JCO.2024.42.3_suppl.611
Abstract #
611
Poster Bd #
H17
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Socioeconomic disparities causing delays in pancreatic cancer germline genetic testing.
First Author: Xianghui Zou
Poster
2023 ASCO Annual Meeting
The impact of social determinants of health (SDOH) on use of germline genetic testing for triple-negative breast cancer (TNBC) in the community oncology setting.
First Author: Robert Lawrence Reid
Poster
2019 Gastrointestinal Cancers Symposium
Impact of an inter-professional clinic on pancreatic cancer outcomes: The Princess Margaret Cancer Centre (PM) experience.
First Author: Hamzeh Albaba
Poster
2024 ASCO Quality Care Symposium
Disparities in neighborhood deprivation and patient reported quality of life relating to post-operative sequelae after radical cystectomy.
First Author: Anosh Dadabhoy